Repligen Corporation to Present at Upcoming November Conferences

Rhea-AI Summary

Repligen (NASDAQ:RGEN) will attend five investor conferences in November 2025 with executive participation and webcasts available. Key events: UBS Global Healthcare (Nov 10–12, Palm Beach Gardens; CFO Jason Garland on Nov 10 at 11:00 a.m. ET), Stifel Healthcare (Nov 11–13, New York; CEO Olivier Loeillot on Nov 11 at 10:00 a.m. ET), Wolfe Research Healthcare (Nov 17–19, New York; CFO Jason Garland on Nov 18 at 12:40 p.m. ET), Jefferies Global Healthcare (Nov 18–20, London; CEO Olivier Loeillot on Nov 18 at 8:30 a.m. ET/1:30 p.m. GMT), and Stephens Annual Investment (Nov 18–20, Nashville; CFO one-on-ones on Nov 19).

A live webcast of presentations will be available on Repligen’s Investor Relations website and replayed for a limited time.

News Market Reaction

-2.16%

1 alert

-2.16% News Effect

On the day this news was published, RGEN declined 2.16%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming investor conferences.

• The UBS Global Healthcare Conference, being held November 10 – 12 in Palm Beach Gardens, FL. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 11:00 a.m. ET on Monday, November 10.
• The Stifel Healthcare Conference, being held November 11 – 13 in New York. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion at 10:00 a.m. ET on Tuesday, November 11.
• The Wolfe Research Healthcare Conference, being held November 17 – 19 in New York. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion at 12:40 p.m. ET on Tuesday, November 18.
• The Jefferies Global Healthcare Conference, being held November 18 – 20 in London, UK. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion at 8:30 a.m. ET/1:30 p.m. Greenwich Mean Time on Tuesday, November 18.
• The Stephens Annual Investment Conference, being held November 18 – 20 in Nashville. Jason Garland, Chief Financial Officer, will participate in a series of one-on-one meetings with investors on Wednesday, November 19.
  

A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com 

FAQ

When will Repligen (RGEN) present at the UBS Global Healthcare Conference?

CFO Jason Garland will participate in an analyst-led discussion on Nov 10, 2025 at 11:00 a.m. ET at UBS Global Healthcare.

What time is Repligen CEO Olivier Loeillot speaking at the Stifel Healthcare Conference (RGEN)?

Olivier Loeillot will participate in an analyst-led discussion on Nov 11, 2025 at 10:00 a.m. ET in New York.

How can investors watch Repligen (RGEN) presentations from the November conferences?

A live webcast of the conference presentations will be accessible via Repligen’s Investor Relations website with replay available for a limited time.

When is Repligen (RGEN) scheduled at the Wolfe Research Healthcare Conference?

CFO Jason Garland is scheduled for an analyst-led discussion on Nov 18, 2025 at 12:40 p.m. ET in New York.

What is the timing for Repligen CEO participation at Jefferies Global Healthcare (RGEN)?

Olivier Loeillot will speak on Nov 18, 2025 at 8:30 a.m. ET / 1:30 p.m. GMT at the Jefferies Global Healthcare Conference in London.

Will Repligen (RGEN) hold investor meetings at the Stephens Annual Investment Conference?

Yes; CFO Jason Garland will hold a series of one-on-one investor meetings on Nov 19, 2025 in Nashville.